KNOWLEDGE CONCLAVE

Trends in Commercial Execution and Expected Challenges

Welcome to the sixth edition of PHARMAFUTURE ™ KNOWLEDGE CONCLAVE.

This year's focus is on the emerging trends in modern commercial execution and the existing as well as expected future challenges. Peer-led panel discussions will highlight success stories about navigating the changing realities of customer needs, with special attention on occasions when innovation has played a key role in the success of initiatives.

Gwenael Meneux VP Commercial Strategy & Excellence AstraZeneca, China

Mr. Gwénaël Meneux is currently VP of Commercial Strategy & Excellence (CSE) at AstraZeneca, China.

Gwénaël joined AstraZeneca France in February 2009 and acted as Sales Force Excellence Director and Customer Excellence Director successively. He joined AstraZeneca, China, in September 2016, leading commercial enabling functions in the areas of Sales Force Excellence & Business Intelligence, Market Research, Marketing and Launch Excellence, Business Planning, Project Management Office, Training & Capability Building and Event Management.

Gwénaël began his career in 1998 at L’Oréal (FMCG division) where he held several sales and marketing positions (sales representative, global & country marketing manager and Marketing Director, Latin America). Later he joined the Boston Consulting Group where he enriched his robust corporate marketing experience with strategic project design and management.

Gwénaël holds a MSc in Management from ESSEC Business School.

Joseph Sheng Vice president of Primary Care Business Unit Sanofi, China

Joseph Sheng joined Sanofi, China, in 2010 as the head of Business Development and Strategic Planning Department and is now leading the Primary Care Business Unit focusing on the China market.

Joseph has been working in the healthcare industry for more than 20 years, taking extensive roles in Sales, Marketing, BD, Strategic planning, etc.

Joseph began his career in Schering-Plough from 1994. Until 2009,where he worked in Roche, Pfizer, Bayer and Philips, gaining various experiences in business arenas of Ethical , OTC and Medical Devices.

Joseph Sheng obtained Bachelor Degree of Pharmacology from Shanghai Medical University and MBA degree from CEIBS.

Victoire Delajudie Customer Innovation Director Sanofi, China

After 3 years consulting at McKinsey, Victoire entered Sanofi in 2009, where she worked in Corporate, Europe, and France affiliate, in both functional and operational roles. Victoire joined Sanofi, China, in May 2015 to tackle affiliate digital transformation.

Victoire holds a Master of Philosophy in Technology Policy, Business Administration and Management from University of Cambridge.

James Yau Head of Omni-channel engagement UCB, China

James Yau is a seasoned Sales and Marketing executive with over 20 years of experience across Asia, including the Greater China region by holding multiple management and leadership roles at UCB Pharma, Unilever, Johnson & Johnson, and Nokia.

James is now leading innovation within the Go-to-Market model by leveraging the power of digital technology to create the best solutions for HCPs and patients. His mission is to transform the conventional pharma engagement approaches into a data-informed, insight-driven, digital-focused, and patient-centric omni-channel platform.

James obtained EMBA in Business Administration from National Chengchi University.

Zig Lang Vice President and Head of Medical Affairs and Pharmacovigilance, Bayer, China

Zhihui (Zig) Lang, M.D., PhD.

Dr. Lang is the Vice President and Head of Medical Affairs and Pharmacovigilance at Bayer Pharmaceuticals, China. In this role, Zig directs the Medical Affairs, Medical Science Liaisons, Medical Communications, Scientific Operations, Medical Compliance, Health Economics and Outcome Research and Pharmacovigilance.

Prior to coming to Bayer China, Zig worked in Bayer’s Global Medical Affairs Oncology in the United States. Zig has 17 years of pharmaceutical industry experiences ranging from early and late stage clinical development to global medical affairs. Zig has also held positions at Endo Pharmaceuticals, Johnson and Johnson, Wyeth and Novo Nordisk.

Zig is a board-certified oncologist and hematologist. He received his medical education at the Fourth Military Medical University in Xi’an and PhD in Biochemistry at Rush University in Chicago.

Henry Sun General Manager, Aktana, China

Henry is responsible for managing Aktana’s operations in China. He brings with him more than 15 years of combined experience in the enterprise software and Life Science industries. Prior to joining Aktana, Henry has held various positions in sales, consulting, and technology development. Most recently, Henry has worked at Veeva China where he led the sales consulting practice’s multichannel innovation initiatives. He has also worked at Microsoft and Merck, before returning to his hometown of Shanghai in 2011.

He attended the State University of New York at Stony Brook where he graduated with Joint Honors in Information Systems Engineering and Strategic Marketing Management.

Nataliya Andreychuk CEO, Viseven Europe OU

Nataliya Andreychuk, CEO at Viseven Group, is a leading expert in digital pharma marketing and CLM implementation. She aims at delivering value for clients in the sphere of their business development at no outrageous cost, but with a good portion of quality and confidence.

Nataliya empowers customers to improve their user experience, avoiding changing their business principals, but helping to develop and perfect them. She has been known for her expertise in the creation of eDetails and has transferred this knowledge to new teams, uniting them through ideas and beneficial goals by providing a clear vision and strategy of the company during its development.

Before joining the Viseven team, Nataliya had a strong background experience in marketing, business analytics and software development. Recently, she has been conducting a number of trainings and master-classes, sharing her expertise and participating in the most impactful healthcare, IT and marketing events.

Meilin Li Head of commercial Operations Gilead, China

Meilin Li is currently head of Commercial Operations, Gilead Sciences, China, responsible for SFE, marketing insights as well as commercial learning and development.

She has close to 20 years of experience in broad spectrum of healthcare. A paediatrician by practice, Meilin has held various positions in pharmaceutical sales, marketing, and consulting.

Agenda 

13:30-13:45
Welcome Note: Indegene

Indegene & Microsoft VPs

KEYNOTE
13:45-14:15
The Evolution of the Commercial Landscape

Preparing for tomorrow's life sciences commercial execution landscape, today

PANEL DISCUSSION
14:15-15:00
Aligning Stakeholder Needs

Aligning the needs of reps, MSLs, and HCPs through Omnipresence marketing

15:00-15:15
Break

Snacks, Beverages, Networking

PANEL DISCUSSION
15:15-16:00
Looking Into the Future

AI-driven content and targeting

16:00-16:15
Closing Remarks

Indegene & Microsoft VPs

16:15-17:30
Cocktails and Networking

 

Event Coverage 

  • China_Event_video 01

    PharmaFuture Knowledge Conclave Grand Reception Entry, Shangri-La, Shanghai

  • China_Event_video 02

    Keynote - Preparing for tomorrow's life sciences commercial execution landscape, today.

  • China_Event_video 03

    A Panel Discussion - Aligning the needs of reps, MSLs, and HCPs through Omnipresence marketing

  • China_Event_video 04

    A Panel Discussion - Looking into the future | AI-driven content and targeting

  • China_Event_video 05

    Closing Remarks - Indegene and Microsoft strategic alliance for intelligent customer engagement and management for life sciences

About  PHARMAFUTURE ™ 

PHARMAFUTURE ™  KNOWLEDGE CONCLAVE is an exclusive event that has been designed to primarily focus on discussions of the challenging issues and successful trends in the pharma industry, thus serving as a significant platform to interact with the senior management across the industry.

PHARMAFUTURE ™  is an initiative of Indegene - a leading global healthcare solutions company that integrates medical/pharmaceutical expertise, technology, analytics, and operational excellence to address some of the major challenges in the industry.